- Home
- RARE vs SMG Comparison
RARE vs SMG Comparison
Compare RARE & SMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- SMG
- Stock Information
- Founded
- RARE 2010
- SMG 1868
- Country
- RARE United States
- SMG United States
- Employees
- RARE N/A
- SMG N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- SMG Agricultural Chemicals
- Sector
- RARE Health Care
- SMG Industrials
- Exchange
- RARE Nasdaq
- SMG Nasdaq
- Market Cap
- RARE 5.2B
- SMG 4.2B
- IPO Year
- RARE 2014
- SMG N/A
- Fundamental
- Price
- RARE $43.98
- SMG $68.40
- Analyst Decision
- RARE Strong Buy
- SMG Hold
- Analyst Count
- RARE 14
- SMG 7
- Target Price
- RARE $88.43
- SMG $77.50
- AVG Volume (30 Days)
- RARE 717.6K
- SMG 807.6K
- Earning Date
- RARE 02-13-2025
- SMG 01-29-2025
- Dividend Yield
- RARE N/A
- SMG 3.85%
- EPS Growth
- RARE N/A
- SMG N/A
- EPS
- RARE N/A
- SMG N/A
- Revenue
- RARE $522,745,000.00
- SMG $3,552,700,000.00
- Revenue This Year
- RARE $27.36
- SMG $1.13
- Revenue Next Year
- RARE $18.61
- SMG $2.67
- P/E Ratio
- RARE N/A
- SMG N/A
- Revenue Growth
- RARE 27.44
- SMG 0.04
- 52 Week Low
- RARE $37.02
- SMG $53.43
- 52 Week High
- RARE $60.37
- SMG $93.90
- Technical
- Relative Strength Index (RSI)
- RARE 33.50
- SMG 29.93
- Support Level
- RARE $41.45
- SMG $72.50
- Resistance Level
- RARE $50.00
- SMG $75.54
- Average True Range (ATR)
- RARE 1.83
- SMG 2.20
- MACD
- RARE -0.31
- SMG -0.61
- Stochastic Oscillator
- RARE 26.55
- SMG 8.79
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About SMG Scotts Miracle-Gro Company (The)
Scotts Miracle-Gro is the largest provider of gardening and lawncare products in the United States. The majority of the company's sales are to large retailers that include Home Depot, Lowe's, and Walmart. Scotts Miracle-Gro can sell its products at a higher price point than its competition because of a well-recognized portfolio of brands that include Miracle-Gro, Roundup, Ortho, Tomcat, and Scotts. Scotts is also the leading supplier of cannabis-growing equipment in North America through its Hawthorne business.